Nuveen’s Merck MRK Stock Holding History

Nuveen’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,000	Closed	-$2K	–	3130
2022 Q4	$2K	Buy	+15,000	New	+$1.53M	﹤0.01%	3169
2020 Q3	–	Sell	-26,200	Closed	-$2K	–	3333
2020 Q2	$2K	Buy	+26,200	New	+$1.97M	﹤0.01%	3256
2016 Q1	–	Sell	-5,240	Closed	-$264	–	1462
2015 Q4	$264	Sell	5,240 -6,288	-55%	-$317K	﹤0.01%	1394
2015 Q3	$543	Hold	11,528	–	–	﹤0.01%	1300
2015 Q2	$626	Sell	11,528 -10,480	-48%	-$588K	﹤0.01%	1303
2015 Q1	$1.21M	Sell	22,008 -54,496	-71%	-$3.09M	0.01%	1084
2014 Q4	$4.15M	Buy	76,504 +1,048	+1%	+$58.4K	0.02%	591
2014 Q3	$4.27M	Sell	75,456 -78,600	-51%	-$4.41M	0.03%	588
2014 Q2	$8.5M	Buy	154,056 +80,696	+110%	+$4.4M	0.05%	408
2014 Q1	$3.97M	Sell	73,360 -36,680	-33%	-$1.9M	0.02%	589
2013 Q4	$5.25M	Sell	110,040 -81,744	-43%	-$3.74M	0.03%	503
2013 Q3	$10M	Buy	191,784 +27,248	+17%	+$1.24M	0.06%	370
2013 Q2	$7.29M	Buy	+164,536	New	+$7.35M	0.05%	422

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nuveen's MRK Position: Q1 2026 in Review

Nuveen increased its Merck (MRK) stake by 45% in Q1 2026, buying an estimated $363M and bringing the position to 10,099,764 shares worth $1.21B. The position accounts for 0.33% of the portfolio, ranked #54.

Nuveen first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.32B in Q4 2019. 3,782 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Nuveen held 10,099,764 shares of Merck worth $1.21B as of Q1 2026.
Nuveen bought 3,141,695 Merck shares in Q1 2026, an estimated $363M.
Merck made up 0.33% of Nuveen's portfolio in Q1 2026, its #54 holding.
Nuveen first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Nuveen's Merck position peaked at $2.32B in Q4 2019.
3,782 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.